Grantham, Mayo, Van Otterloo & Co (GMO)’s Levi Strauss LEVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$403K Sell
16,231
-8,484
-34% -$191K ﹤0.01% 582
2026
Q1
$457K Buy
24,715
+6,012
+32% +$123K ﹤0.01% 559
2025
Q4
$388K Buy
+18,703
New +$403K ﹤0.01% 598
2021
Q1
Sell
-150,200
Closed -$3.02M 900
2020
Q4
$3.02M Buy
+150,200
New +$2.69M 0.02% 374

Other funds holding LEVI

Grantham, Mayo, Van Otterloo & Co (GMO)'s LEVI Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Levi Strauss (LEVI) stake by 34% in Q2 2026, selling an estimated $191K and leaving 16,231 shares worth $403K. The position accounts for ﹤0.01% of the portfolio, ranked #582.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in LEVI in Q4 2020 and has held it in 4 quarters since. The position peaked at $3.02M in Q4 2020. 315 funds tracked by Wall St. Rank hold LEVI as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 16,231 shares of Levi Strauss worth $403K as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 8,484 Levi Strauss shares in Q2 2026, an estimated $191K.
  • Levi Strauss made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #582 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Levi Strauss in Q4 2020 and has held it in 4 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Levi Strauss position peaked at $3.02M in Q4 2020.
  • 315 funds tracked by Wall St. Rank held Levi Strauss as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.